Hedley D W, Nyholm R E, Currie G A
Br J Cancer. 1979 May;39(5):558-65. doi: 10.1038/bjc.1979.101.
Assays for the capacity of peripheral-blood monocytes (a) to mature in vitro into macrophages, (b) to reduce nitro-blue tetrazolium (NBT) and (c) to lyse antibody-coated human Group A red cells, were applied to a group of 82 patients with histologically proven malignant melanoma. In patients with micrometastatic disease there was an enhancement of red-cell lysis and NBT reduction, suggesting that their monocytes are in some way "activated", whereas NBT reduction was suppressed in those with overt dissemination. Monocyte maturation in vitro was impaired in all patient groups to an extent which correlated with overall tumour burden. Corynebacterium parvum was administered i.v. to 12 patients with disseminated disease and by the intradermal route to 24 patients with micrometastatic disease. The 3 monocyte functions were significantly enhanced by C. parvum.
(a) 在体外成熟为巨噬细胞的能力;(b) 还原硝基蓝四氮唑(NBT)的能力;(c) 裂解抗体包被的人A 型红细胞的能力。将这些检测应用于一组82例经组织学证实的恶性黑色素瘤患者。在有微转移疾病的患者中,红细胞裂解和NBT还原增强,提示他们的单核细胞在某种程度上被“激活”,而在有明显播散的患者中NBT还原受到抑制。所有患者组的单核细胞体外成熟均受损,其受损程度与总体肿瘤负荷相关。对12例播散性疾病患者静脉注射短小棒状杆菌,对24例微转移疾病患者进行皮内注射。短小棒状杆菌显著增强了这三种单核细胞功能。